Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$225K |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$208K |
| 3 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$176K |
| 4 |
Tesla
TSLA
|
+$176K |
| 5 |
Meta Platforms (Facebook)
META
|
+$174K |
Top Sells
| 1 |
TECD
Tech Data Corp
TECD
|
+$186M |
| 2 |
MINI
Mobile Mini Inc
MINI
|
+$92.3M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$91.9M |
| 4 |
TVIX
VelocityShares Daily 2x VIX Short Term ETN
TVIX
|
+$77.9M |
| 5 |
Kraft Heinz
KHC
|
+$60.1M |
Sector Composition
| 1 | Healthcare | 15.67% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Technology | 11.33% |
| 4 | Industrials | 10.91% |
| 5 | Financials | 10.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RRD
2226
DELISTED
RR Donnelley & Sons Co.
RRD
| $1.36K | ﹤0.01% |
933,993
-88,065
| -9% | -$129 |
|
2227
AppFolio
APPF
$9.9B
| $1.36K | ﹤0.01% |
9,604
-5,263
| -35% | -$746 |
|
2228
Ultrapar
UGP
$4.1B
| $1.36K | ﹤0.01% |
398,264
-1,402,200
| -78% | -$4.8K |
|
2229
John Wiley & Sons Class A
WLY
$2.19B
| $1.36K | ﹤0.01% |
42,943
-101,566
| -70% | -$3.22K |
|
|
PANA.U
2230
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
| $1.36K | ﹤0.01% |
+113,503
| New | +$1.36K |
|
2231
Public Service Enterprise Group
PEG
$41.3B
| $1.36K | ﹤0.01% |
24,756
-111,783
| -82% | -$6.14K |
|
2232
Gates Industrial
GTES
$6.6B
| $1.36K | ﹤0.01% |
121,922
-17,611
| -13% | -$196 |
|
2233
Ally Financial
ALLY
$13B
| $1.35K | ﹤0.01% |
53,994
-598,347
| -92% | -$15K |
|
2234
Kodiak Sciences
KOD
$489M
| $1.35K | ﹤0.01% |
22,876
-96,110
| -81% | -$5.69K |
|
2235
Celsius Holdings
CELH
$14.9B
| $1.35K | ﹤0.01% |
+178,122
| New | +$1.35K |
|
2236
Moog
MOG.A
$6.27B
| $1.35K | ﹤0.01% |
21,226
-143,173
| -87% | -$9.09K |
|
|
ARNC
2237
DELISTED
Arconic Corporation
ARNC
| $1.35K | ﹤0.01% |
+70,718
| New | +$1.35K |
|
2238
FRP Holdings
FRPH
$483M
| $1.35K | ﹤0.01% |
64,560
-3,178
| -5% | -$66 |
|
2239
MakeMyTrip
MMYT
$9.31B
| $1.35K | ﹤0.01% |
87,585
-5,891
| -6% | -$90 |
|
2240
Heritage Insurance Holdings
HRTG
$763M
| $1.34K | ﹤0.01% |
132,515
-47,611
| -26% | -$482 |
|
|
MNTV
2241
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.34K | ﹤0.01% |
60,672
+21,607
| +55% | +$478 |
|
2242
Wolfspeed
WOLF
$365M
| $1.34K | ﹤0.01% |
21,010
-41,144
| -66% | -$2.62K |
|
|
APTS
2243
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $1.34K | ﹤0.01% |
247,957
-164,314
| -40% | -$887 |
|
2244
AC Immune
ACIU
$244M
| $1.34K | ﹤0.01% |
274,129
-243,107
| -47% | -$1.19K |
|
|
CS
2245
DELISTED
Credit Suisse Group
CS
| $1.34K | ﹤0.01% |
134,178
-83,075
| -38% | -$828 |
|
2246
Novanta
NOVT
$4.12B
| $1.34K | ﹤0.01% |
+12,680
| New | +$1.34K |
|
|
SYRS
2247
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.34K | ﹤0.01% |
15,103
-203
| -1% | -$18 |
|
2248
AB InBev
BUD
$114B
| $1.33K | ﹤0.01% |
24,743
+14,946
| +153% | +$805 |
|
2249
Cardiff Oncology
CRDF
$136M
| $1.33K | ﹤0.01% |
+93,953
| New | +$1.33K |
|
|
SRRA
2250
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.33K | ﹤0.01% |
+124,766
| New | +$1.33K |
|